We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
EVALUATION DU TRAITEMENT ANTIRETROVIRAL CHEZ L'ADULTE INFECTE PAR LE VIH AU SERVICE DE DERMATOLOGIE VENEREOLOGIE DE L'HOPITAL NATIONAL DONKA.
- Authors
CISSE, M.; SAKO, F. B.; DIABY, B.; SOUMAH, M. M.; TOUNKARA, T. M.; DIANE, B. F.; BALDE, H.; CAMARA, A. D.; CAMARA, A.
- Abstract
If the use of the highly active antiretroviral therapies (HAART) have largely improved survival, morbidity and the quality of life of the people living with HIV in Northern countries as well as Southern countries and particularly in Africa, many obstacles have slowed down their use. Thus the follow-up of the patients under HAART in certain developing countries is still timid even non-existent. Objective : The objective of this work was to bring the therapeutic outcomes obtained after a minimal six months period of follow-up among patients VIH+ admitted in external consultations or following hospitalizations. Material and methods : We carried out a retrospective and descriptive study concerning patients followed from January 1st, 2004 to December 31st, 2008, that is to say 5 years. Results : Our study concerned 275 patients including 61.41% women with a sex-ratio (M/W) 0.62. The median age of our patients was of 36.83 [18 70]. The initial average weight of our patients was 59.88 kg [30 -107] with the majority (66.91%) at the stage III of the clinical classification of WHO. The serologic profile was dominated by the HIV1 (97.09%) with a number of average CD4 with 210.99 cellules/mm3à the initiation of treatment ARV. The evolution under treatment was marked clinically by an average ponderal profit of 7,45kg, the middleweight passing 59.88 kg to 67.33 kg between M0 and M54. Biologically, the number of average CD4 passed from 210.99 to 643 between M0 and M48 is an average profit of 432.01 cells/mm3. On the virological level, the plasmatic viral load carried out for 64 patients out of 275. It was undetectable for 31 patients, be it 48.44%. In conclusion, the therapeutic outcomes of the patients under HAART was good at the end of this study with a satisfactory clinical issue, marked by an increase in the average weight which corroborates an immunological and virological good response.
- Publication
Mali Médical, 2013, Vol 28, Issue 1, p20
- ISSN
0464-7874
- Publication type
Article